ArticleFrontiers in oncology2022

Combinatory analysis of immune cell subsets and tumor-specific genetic variants predict clinical response to PD-1 blockade in patients with non-small cell lung cancer.

Nikita Dutta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.